Fresenius Medical Care AG & Co. KGaA

Legal Proceedings Report • Oct 27, 2004

News Details

Ad-hoc | 27 October 2004 07:45

Fresenius Medical Care reports receipt of DOJ subpoena

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Fresenius Medical Care reports receipt of DOJ subpoena Fresenius Medical Care AG (“the Company”) (Frankfurt Stock Exchange: FME, FME3) (NYSE: FMS, FMS-p), the world’s largest provider of Dialysis Products and Services, today announced that its wholly owned subsidiaries, Fresenius Medical Care Holdings, Inc. and Spectra Renal Management, received on October 26, 2004 subpoenas from the U.S. Department of Justice, Eastern District of New York. The subpoenas require production of a broad range of documents relating to the company’s operations, with specific attention to documents relating to testing for parathyroid hormone (PTH) levels and vitamin D therapies. The company will cooperate with the government’s investigation. Fresenius Medical Care North America (“FMC-NA”) has operated since 1999 with one of the leading compliance programs in the US healthcare industry. The company is firmly committed to compliance; the rigorous compliance program involves ongoing evaluation of business operations, compliance training for all employees, and audits of laboratory and dialysis services programs. FMC- NA’s compliance program and its compliance audits, are subject to review each year by an independent review organization, and FMC-NA reports the results to the Office of the Inspector General. The company will seek to meet with representatives of the government to discuss the issues addressed in the subpoena and is optimistic that the controls imbedded in the compliance program will be well received. Fresenius AG (WKN 578560, 578563) holds a majority interest in Fresenius Medical Care’s ordinary capital. Fresenius Medical Care AG, Board of Management, Bad Homburg v.d.H., October 27, 2004 end of ad-hoc-announcement (c)DGAP 27.10.2004 ——————————————————————————– WKN: 578580; ISIN: DE0005785802; Index: DAX Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 270745 Okt 04